Effect of weight gain on blood pressure in Ugandan persons with HIV on dolutegravir/lamivudine/ tenofovir disoproxil fumarate over 48 weeks
We provide additional evidence to suggest that the noticed weight gain after starting dolutegravir based ART may be associated with a heightened risk of incident hypertension.
Authors
- B. Nixon
- Nele Brusselaers (ORCID: https://orcid.org/0000-0003-0137-447X)
- Martin Nabwana (ORCID: https://orcid.org/0000-0003-1727-9813)
- Jean‐Marc Schwarz
- Frank Mulindwa (ORCID: https://orcid.org/0000-0003-4831-1185)
- Barbara Castelnuovo (ORCID: https://orcid.org/0000-0001-7756-5032)
- Brendan Maloney
- Willington Amutuhaire (ORCID: https://orcid.org/0009-0006-4214-0206)
- Lal Muhammad
Institutions
- University of Antwerp (BE)
- University of California, San Francisco (US)
- SUNY Upstate Medical University (US)
- Touro University California (US)
- Karolinska Institutet (SE)
- Yale University (US)
- Wilson Hospital (GB)
- United Health Services (US)
- Infectious Diseases Institute (UG)
- MUJHU Research Collaboration (UG)
- Makerere University (UG)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1371/journal.pone.0325020
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fogarty International Center
- Center for AIDS Research, University of California, San Diego